Between 1986 and 2003, 43 eligible patients were identified, 29 female and 14 male, ranging in age from 32 years to 88 years at the time of diagnosis. The majority of patients were aged between 50 and ...
Objectives The TREAT EARLIER trial showed in clinically suspect arthralgia (CSA) that methotrexate induced reductions in ...
Please provide your email address to receive an email when new articles are posted on . Low-dose methotrexate did not relieve pain or reduce synovitis in inflammatory knee OA. The findings do not ...
Methotrexate significantly lowers systolic blood pressure in newly diagnosed RA patients compared to sulfasalazine, potentially reducing cardiovascular risk. The study provides prospective comparative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback